| RS2495972526 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495972945 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2495973807 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495973867 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495974544 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495974647 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2495974734 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495975051 |
ERCC6
|
Health Risk |
Likely pathogenic |
— |
| RS2495975869 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS2495977429 |
FERMT3
|
Health Risk |
Likely pathogenic |
Leukocyte adhesion deficiency 3, Leukocyte adhesion deficiency 3 |
| RS2495978149 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495978266 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2495980482 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495980573 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2495980701 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495980915 |
ERCC6
|
Health Risk |
Likely pathogenic |
— |
| RS2495981397 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2495982356 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2495982495 |
IGHMBP2
|
Health Risk |
Likely pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2495982812 |
CLPB
|
Health Risk |
Pathogenic |
Neutropenia, severe congenital |
| RS2495982918 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2495982991 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495983908 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2495984482 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495984631 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2495984647 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2495990286 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2495990477 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495990583 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2495990647 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2495994026 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2495995561 |
DNAJB13
|
Health Risk |
Likely pathogenic |
— |
| RS2495995968 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2495996016 |
ERCC6
|
Health Risk |
Pathogenic |
Cerebrooculofacioskeletal syndrome 1, Cerebrooculofacioskeletal syndrome 1 |
| RS2496000368 |
SF3B2
|
Health Risk |
Pathogenic |
Craniofacial microsomia 1, Craniofacial microsomia 1 |
| RS2496002045 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2496002747 |
PAX6
|
Health Risk |
Pathogenic |
Coloboma, ocular |
| RS2496003605 |
PAX6
|
Health Risk |
Pathogenic |
Congenital aniridia, Congenital aniridia |
| RS2496004464 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental disorder, Isolated optic nerve hypoplasia |
| RS2496006701 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2496006798 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2496006893 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2496007406 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2496008937 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2496008939 |
RELT
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta, Amelogenesis imperfecta |
| RS2496008991 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2496009062 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2496009092 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2496009170 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2496009185 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2496013240 |
PGM2L1
|
Health Risk |
Pathogenic |
— |
| RS2496013518 |
CLPB
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS2496016889 |
FERMT3
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 3, Leukocyte adhesion deficiency 3 |
| RS2496020401 |
AMOTL1
|
Health Risk |
Pathogenic |
Craniofaciocardiohepatic syndrome, Craniofaciocardiohepatic syndrome |
| RS2496022254 |
MYPN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1KK, Dilated cardiomyopathy 1KK |
| RS2496022258 |
MYPN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1KK, Dilated cardiomyopathy 1KK |
| RS2496024369 |
SCYL1
|
Health Risk |
Likely pathogenic |
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome, Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome |
| RS2496026698 |
CAPRIN1
|
Health Risk |
Likely pathogenic |
Autistic behavior, Moderate intellectual disability |
| RS2496031806 |
FERMT3
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 3, Leukocyte adhesion deficiency 3 |
| RS2496032960 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2496033253 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2496033437 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2496033440 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496034507 |
IGHMBP2
|
Health Risk |
Likely pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Autosomal recessive distal spinal muscular atrophy 1 |
| RS2496034612 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496034725 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496034758 |
IGHMBP2
|
Health Risk |
Likely pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496049330 |
CEP57
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 2, Mosaic variegated aneuploidy syndrome 2 |
| RS2496049730 |
FERMT3
|
Health Risk |
Likely pathogenic |
Leukocyte adhesion deficiency 3, Leukocyte adhesion deficiency 3 |
| RS2496050378 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2496050980 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS2496050991 |
PSMC3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2496051000 |
ERCC6
|
Health Risk |
Likely pathogenic |
— |
| RS2496054182 |
IGHMBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496055707 |
PSMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2496056054 |
PSMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2496062221 |
IGHMBP2
|
Health Risk |
Likely pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496064359 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2496065853 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496067678 |
CAPRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with language impairment, autism |
| RS2496067951 |
CAPRIN1
|
Health Risk |
Pathogenic |
Juvenile myoclonic epilepsy, Juvenile myoclonic epilepsy |
| RS2496067959 |
CAPRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with language impairment, autism |
| RS2496070562 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496070621 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496076667 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496078103 |
CAPRIN1
|
Health Risk |
Pathogenic |
— |
| RS2496079413 |
CAPRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with language impairment, autism |
| RS2496080518 |
RAPSN
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 2, Fetal akinesia deformation sequence 2 |
| RS2496080823 |
RAPSN
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 2, Fetal akinesia deformation sequence 2 |
| RS2496080892 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2496086381 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496086396 |
PLCE1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 3 |
| RS2496086694 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2496086825 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2496087067 |
RAPSN
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 2, Fetal akinesia deformation sequence 2 |
| RS2496097284 |
RAPSN
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 2, Congenital myasthenic syndrome 11 |
| RS2496097769 |
CAPRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration, childhood-onset |
| RS2496099745 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 2, Fetal akinesia deformation sequence 2 |
| RS2496099950 |
RAPSN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS2496099964 |
RAPSN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |